«HSP90 inhibitors: current development and potential in cancer therapy.». Recent Pat. Anticancer Drug Discov., 9, 1, 1-2014, pàg. 1–20. DOI: 10.2174/15748928113089990031. PMID: 23312026.
«Heat shock protein 90: Inhibitors in clinical trials.». J. Med. Chem., 53, 1, 1-2010, pàg. 3–17. DOI: 10.1021/jm9004708. PMID: 20055425.
hathitrust.org
babel.hathitrust.org
H. Hlasiwetz and L. Barth (1864) "Ueber einen neuen, dem Orcin homologen Körper" (On a new substance homologous to orcin), Annalen der Chemie, 130 (3) : 354-359. Resorcinol is named on p. 358: "Wir nennen den neuen Körper, da wir gefunden haben, dass er auch aus dem Ammoniakgummiharz erhalten werden kann, Resorcin, um an seine Entstehung aus Harzen und seine Beziehung zum Orcin zu erinnern." (We name the new substance, since we've found that it can be obtained from ammoniated resin gum, resorcin, in order to recall its creation from resin and its relation to orcin [i.e., orcinol].)
nih.gov
ncbi.nlm.nih.gov
«HSP90 inhibitors: current development and potential in cancer therapy.». Recent Pat. Anticancer Drug Discov., 9, 1, 1-2014, pàg. 1–20. DOI: 10.2174/15748928113089990031. PMID: 23312026.
«Heat shock protein 90: Inhibitors in clinical trials.». J. Med. Chem., 53, 1, 1-2010, pàg. 3–17. DOI: 10.1021/jm9004708. PMID: 20055425.
